A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma

Published:2008-10 Issue:4 Volume:81 Page:247-252
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

von Lilienfeld-Toal Marie,Hahn-Ast Corinna,Furkert Kerstin,Hoffmann Florian,Naumann Ralph,Bargou Ralf,Cook Gordon,Glasmacher Axel

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2008.01121.x/fullpdf

Reference19 articles.

1. A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma;Glasmacher;Br J Haematol,2006

2. An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma;Prince;Leuk Lymphoma,2007

3. Thalidomide and dexamethasone for resistant multiple myeloma;Anagnostopoulos;Br J Haematol,2003

4. Thalidomide and dexamethasone combination for refractory multiple myeloma;Dimopoulos;Ann Oncol,2001

5. Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma;Palumbo;Hematol J,2004

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects;Targets;2024-06-13

2. A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma;Drug Delivery and Translational Research;2023-01-02

3. What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma;Targeted Oncology;2022-06-30

4. Dexamethasone and Citicoline mitigate Cisplatin-induced peripheral neuropathy: A novel experimental study in Mice;Turkish Journal of Pharmaceutical Sciences;2021-11-17

5. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment;Oncology and Therapy;2021-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3